welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Pharmacological and Dietary Prevention for Colorectal Cancer
source: BMC surgery
authors: Francesca Nolfo, Stefania Rametta, Stefano Marventano, Giuseppe Grosso, Antonio Mistretta, Filippo Drago, Santi Gangi, Francesco Basile, Antonio Biondisummary/abstract:
Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate the chemopreventive role of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and cyclooxygenase 2 inhibitors, some micronutrients (folic acid, calcium, selenium, antioxidants) and probiotics.
The studies on aspiring reported promising results, but it is debatable whether aspirin should be used as chemoprevention, because of its side effects and because of poor efficacy evident in subjects at high risk. Similar results were reported for other non-aspirin NSAIDs, such as sulindac and celecoxib, which the potential adverse effects limit their use. Selenium role in prevention of various types of cancer as well as in colon adenomas are often inconclusive or controversial. Several studies suggested that calcium may have a possible chemopreventive effect on colon adenomas and CRC, although contrasting results are reported for the latter. A recent meta-analysis including 13 randomized trial suggested that folic acid supplementation had not a chemiopreventive action on CRC. Several studies investigated the association between antioxidants, administered alone or in combination, and CRC risk, both among general and at risk population, but only few of them supported statistically significant results.
The results of this literature review showed an unclear role in CRC prevention of both pharmacological and dietary intervention. Despite several options are available to prevent colon cancer, it is challenging to identify a correct strategy to prevent CRC through pharmacological and dietary intervention due to the long latency of cancer promotion and development. Since some of the drugs investigated may have uncertain individual effects, it can be suggested to potentiate such effects by adding them together.
read more full text source
expertly curated content related to this topic
BCIR – Olympia Medical Center Los Angeleshttps://www.youtube.com/channel/UCEdZLy_...
A Useful Reconstruction Arrangement Following Whipple’s Resection for Patients with Familial Adenomatous Polyp...BACKGROUND Peri-ampullary carcinoma i...
Ambry Genetics: Travis Bray – Living with F.A.P.https://youtu.be/hEjVQH_gI1M...
Desmoid Tumors — Dangerous when not Treated as Cancerhttps://www.youtube.com/watch?v=gPcEJ8kA...
Prevalence and Outcome of Anemia After Restorative Proctocolectomy: A Clinical Literature ReviewPURPOSE : Iron and/or vitamin B12 defici...
APC-Associated Polyposis ConditionsCLINICAL CHARACTERISTICS : APC-associate...
Endoscopic Management of Familial Adenomatous Polyposis in Patients Refusing ColectomyBACKGROUND AND STUDY AIMS: Colectomy pr...